Neurotrope begins phase 2b study of Bryostatin to treat Alzheimer’s
NEWARK: Neurotrope, Inc (NTRP) has announced the initiation of a phase 2b clinical trial of…
FEATURED
Research team discover ‘game-changer’ to reverse Alzheimer’s disease
New treatment to delay or reverse alzheimers step closer
Tens of thousands to be recruited into Alzheimer’s trials after landmark drug rejected
Thousands of dementia sufferers are being denied new miracle drug
Study pinpoints mealtime issues in nursing home residents with dementia
New rays of hope in fight to slow early Alzheimer’s
INNOVATION
